Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Lupus Miliaris Disseminatus Faciei

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Lupus Miliaris Disseminatus Faciei

Nathaniel Slater et al.
Free Books & Documents

Excerpt

Lupus miliaris disseminatus faciei (LMDF) is primarily an idiopathic granulomatous disease affecting facial skin, particularly the eyelids. Nosologically, this condition is on a spectrum of facial granulomatous dermatoses and shares overlapping features with rosacea and sarcoidosis; however, a differentiating feature is the presence of caseous necrosis (separating it from sarcoidosis) and the lack of photoaggravation and erythema (separating it from rosacea). In most cases, this disorder resolves spontaneously within several years but can leave potentially disfiguring scarring.

The diagnosis was reportedly first noted in 1878 by Fox and colleagues. The name derives from a historical association with tuberculosis based on its clinical and histopathologic appearance of granulomas. More recent authors have proposed adopting the term facial idiopathic granulomas with regressive evolution instead of the entrenched LMDF. However, a name change has not appeared to be widely accepted. Older terms for a similar facial granulomatous dermatosis include micropapular tuberculid, Lewandowsky eruption, and lupoid rosacea. Acne agminata has been used to refer to similar lesions in the axilla. However, most authors consider LMDF a unique entity separate from other diagnoses.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Nathaniel Slater declares no relevant financial relationships with ineligible companies.

Disclosure: Nishad Sathe declares no relevant financial relationships with ineligible companies.

Disclosure: Ronald Rapini declares no relevant financial relationships with ineligible companies.

References

    1. Lenders D, Lenders MM, Jäger M, Schaller M. Treatment of aseptic facial granuloma as a manifestation of pediatric rosacea with oral macrolides. Pediatr Dermatol. 2023 Nov-Dec;40(6):1064-1067. - PubMed
    1. Gorham NC, Jacobs J, Wu SZ. Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream. JAMA Dermatol. 2023 Jul 01;159(7):790-791. - PubMed
    1. Almutairi RS, Al-Sabah HY. Facial Granulomatous Rosacea: A Case Report. Cureus. 2023 Sep;15(9):e45391. - PMC - PubMed
    1. Toda-Brito H, Aranha JMP, Tavares ES. Lupus miliaris disseminatus faciei. An Bras Dermatol. 2017 Nov-Dec;92(6):851-853. - PMC - PubMed
    1. Al-Mutairi N. Nosology and therapeutic options for lupus miliaris disseminatus faciei. J Dermatol. 2011 Sep;38(9):864-73. - PubMed

Publication types

LinkOut - more resources